Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
Public ClinicalTrials.gov record NCT00176605. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Trial of Metronomic Dosing of Etoposide and Cyclophosphamide in Patients With Stage D0 Prostate Cancer.
Study identification
- NCT ID
- NCT00176605
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Rutgers, The State University of New Jersey
- Other
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- Cyclophosphamide Drug
- Etoposide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2005
- Primary completion
- Sep 30, 2008
- Completion
- Sep 30, 2008
- Last update posted
- May 19, 2014
2005 – 2008
United States locations
- U.S. sites
- 7
- U.S. states
- 1
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Jersey Oncology Center | East Brunswick | New Jersey | 08816 | — |
| Robert Wood Johnson University Hospital/CINJ at Hamilton | Hamilton | New Jersey | 08690 | — |
| Morristown Memorial Hospital | Morristown | New Jersey | 07962 | — |
| Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | — |
| Saint Peter's University Hospital | New Brunswick | New Jersey | 08903 | — |
| UMDNJ/Robert Wood Johnson Medical School | Newark | New Jersey | 07103 | — |
| Overlook Hospital | Summit | New Jersey | 070901 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00176605, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2014 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00176605 live on ClinicalTrials.gov.